CN101417003A - Traditional Chinese medicine composition for treating vertebras disease - Google Patents
Traditional Chinese medicine composition for treating vertebras disease Download PDFInfo
- Publication number
- CN101417003A CN101417003A CNA2008102286756A CN200810228675A CN101417003A CN 101417003 A CN101417003 A CN 101417003A CN A2008102286756 A CNA2008102286756 A CN A2008102286756A CN 200810228675 A CN200810228675 A CN 200810228675A CN 101417003 A CN101417003 A CN 101417003A
- Authority
- CN
- China
- Prior art keywords
- parts
- kilograms
- radix
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating spondylopathy. The raw material medicine of the traditional Chinese medicine composition contains herba lycopodli, radices puerarire, tuberculate speranskia herb and fructus liquidambaris. The herba lycopodli used in the prescription has the functions of eliminating pathogenic wind and dampness and relaxing tendons and collaterals; as the monarch drug in the prescription, the herba lycopodli and the tuberculate speranskia herb have the functions of detoxification and analgesia; the fructus liquidambaris can smooth meridian. Therefore, rational administration of the medicine can be conducted according to specific spondylopathy patients, and with starting from the origin of the disease and treating step by step, the medicine can achive the effect of symptomatic and radical treatment.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition that is used for the treatment of vertebra position diseases such as lumbar intervertebral disc prolapse and cervical vertebra.
Background technology
Modern medicine shows, the pathogeny of vertebrae disease is because of vertebra intervertebral disc, ligament, muscle, fascia etc. degeneration and secondary change to take place, stimulate or oppressed around tissues such as spinal cord, nerve, blood vessel, produce a series of comprehensive syndromes such as lumbago and skelalgia, numb limbs and tense tendons, headache and dizzy thus.The method of treatment vertebrae disease comprises drug therapy and operative therapy at present, and the physical therapy method, and wherein physical therapy method majority is to utilize apparatus that vertebra is drawn, though the physical therapy method is simple, cost is lower, but it is applicable to early stage patient, and for patient with severe symptoms's DeGrain; Operative therapy is the main means of western medical treatment vertebrae disease, also is a kind of Therapeutic Method that most patient with severe symptoms adopted, but this kind method has bigger risk for the patient, causes postoperative sequela easily, influences the rehabilitation of patient's postoperative; In Drug therapy, Western medicine has antiinflammatories such as non-sharp sterin and the acid of isobutylbenzene propyl benzene, ease pain and the medicine of the function of bringing down a fever, and the patient takes these medicines and has side effect such as nauseating, vomiting, loss of appetite, and can not effect a radical cure.
Theory of Chinese medical science thinks that vertebrae disease morbidity main cause is the liver hypoimmunity, and physiological function is undesired to be caused; Gallbladder is the secondary cause of vertebrae disease morbidity; In addition, kidney and heart are suffered from deficient syndrome or the case of a physically strong patient running a high fever also is a factor of vertebrae disease morbidity.Because " liver governing tendons ", muscle comprise soft tissues such as muscle tendon, ligament, joint capsule, blood vessel, and intervertebral disc is made up of cartilaginous lamina, vertebral pulp and fibrous ring three parts, belongs to the category of muscle, and vertebrae disease is because fibrous ring generation pathological changes mostly; Liver is cloudy, and gallbladder is a sun, when the negative and positive disequilibrium, also can produce disease; And kidney is the mother of liver, and the heart is the son of liver, illness of the mother organ affecting the child one, and illness of the child-organ affecting the motherone is so kidney and heart relate to liver, and then muscle and tendon injury.According to the Chinese medicine that theory of Chinese medical science is made, should have the function that improves liver immunity and regulate the liver and gall negative and positive, and can also doublely control kidney and the heart deficient syndrome or the case of a physically strong patient running a high fever.
Xu Zhongwen has described a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, sciatica in the CN1413639A patent.This Chinese medicine composition comprises raw material of Chinese medicine such as Radix Dipsaci, Forsyihia viridissima Lindl, Caulis Spatholobi, the Cortex Eucommiae, Semen Cuscutae, Radix Rhapontici, Radix Codonopsis, the Radix Rehmanniae, Rhizoma Drynariae.Forsyihia viridissima Lindl in the crude drug, Caulis Spatholobi, the Cortex Eucommiae and Radix Dipsaci have the tonifying liver and kidney and strengthening bones and muscles effect, and Semen Cuscutae and Radix Rhapontici can play detumescence, sharp joint the kidney invigorating and essence nourishing, go principal agent scorching with Radix Codonopsis, the Radix Rehmanniae, Rhizoma Drynariae, use the Ramulus Cinnamomi coordinating the actions of various ingredients in a prescription.Whether this Chinese medicine composition lays particular emphasis on the kidney invigorating, should be able to play a role for the vertebrae disease that the deficient syndrome or the case of a physically strong patient running a high fever by kidney cause, and can effective in curely await further to inquire into for vertebrae disease uneven because of the liver and gall negative and positive or that other reason causes.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition that utilizes the mode that improves liver immunity or adjust the liver and gall equilibrium between yin and yang to treat vertebrae disease.
The Chinese medicine composition of treatment vertebrae disease of the present invention comprises following row bulk drugs: 20-50 parts of Herba Lycopodiis, 10-30 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris.Wherein, Herba Lycopodii is returned the liver,kidney,spleen warp, has expelling wind and removing dampness, the effect of relaxing muscles and tendons and activating QI and blood in the collateral; Radix Puerariae is returned the taste warp, has relieving the exterior syndrome with drugs of pungent in flavor and cool in nature, and expelling pathogenic factors from muscles for reducing heat selects for use Radix Puerariae mainly to detoxify with it; Herba speranskiae tuberculatae is returned Liver Channel, has expelling wind and removing dampness, the effect of detoxifcation pain relieving; Fructus Liquidambaris is returned liver, diuretic, mediation 12 warps, and the energy expelling wind and removing dampness can be treated arthralgia, numb spasm.
Described Chinese medicine composition also comprises 10-15 parts of Radixs Stephaniae Tetrandrae, 20-50 parts of Rhizoma Homalomenaes, 20-40 parts of Rhizoma Cibotii, 20-40 parts of Radix Notoginseng.Radix Stephaniae Tetrandrae is returned bladder, kidney, spleen, lung meridian, has expelling wind and removing dampness, the analgesic effect; Rhizoma Homalomenae is returned kidney, Liver Channel, has expelling wind and removing dampness, muscle reinforcing and bone strengthening, analgesic effect; Rhizoma Cibotii is also returned liver, kidney channel, is usually used in invigorating the liver and kidney, strong waist knee joint, and expelling wind and removing dampness weighs down the expectorant therapeutic method to keep the adverse QI flowing downwards, checking hyperfunction of the liver for relieving convulsion; Radix Notoginseng returns liver, kidney channel, and it has the hemostasis for the treatment of blood disorders dissipating blood stasis, and the effect of reducing swelling and alleviating pain is the good medicine of the blood circulation promoting and blood stasis dispelling of traumatology indispensability.
Described Chinese medicine composition also comprises 20-40 parts of Rhizoma Et Radix Notopterygiis, 20-40 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss.Rhizoma Et Radix Notopterygii returns kidney channel, and expelling wind and dampness for relieving pain is used for anemofrigid-damp arthralgia, arthrodynia of extremities, aching pain in should and back; Radix Clematidis is returned urinary bladder channel, is used for rheumatic arthralgia, numb limbs and tense tendons, and the contracture of muscle arteries and veins, the joint joint stuffiness, according to motherland's traditional medicine masterpiece Compendium of Material Medica record, Radix Clematidis is a yang aspect of yin, can rise to fall; Radix Phytolaccae is returned lung, kidney, large intestine channel, has the effect of dispersing swelling and dissipating binds; Flos Caryophylli returns kidney channel, and it has the effect of warming middle-JIAO to send down the adverse QI; Squama Manis is returned liver, kidney channel, has detumescence and apocenosis, the effect of expel wind to dredge collateral, Compendium of Material Medica record Squama Manis has except that the intermittent fever due to phlegm cold and heat the tetanic pain of migratory arthralgia, qualcomm meridian, following milk, subduing inflammation, evacuation of pus blood, the sensible property of medicine, the present invention selects the medicine of this property of medicine of Squama Manis " be apt to away and do not keep " for use, mainly play and the monarch and his subjects are helped three groups of medicines combine, guide treating that these three groups of medicines more shoot the arrow at the target, belong to the medicine of guiding at lesions position.
Described Chinese medicine composition also comprises 20-40 parts of Radix Dipsacis, 10-30 parts of Rhizoma Curculiginises, 10-15 parts of Rhizoma Cimicifugaes, 10-30 parts of Rhizoma Corydalis Decumbentiss, 10-30 parts on Flos Carthami, 10-30 parts of Herba Sarcandraes.Radix Dipsaci is returned the Liver and kidney warp, has the promoting the circulation of blood arteries and veins, the effect of invigorating the liver and kidney, bone and muscle strengthening; Rhizoma Curculiginis returns the kidney,liver,spleen warp, has warming the kidney to invigorate YANG, the effect of cold relieving damp eliminating; Rhizoma Cimicifugae is returned lung, spleen, stomach warp, has the rash of delivering, the effect of heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy; Rhizoma Corydalis Decumbentis is returned kidney, heart channel, have invigorate blood circulation, the effect of pain relieving, collateral dredging; Flos Carthami can have treating blood disorders invigorates blood circulation, and blood stasis dispelling stimulates the menstrual flow; Herba Sarcandrae is returned kidney channel, the effect of tool anti-inflammatory analgetic, dispelling wind and removing obstruction in the collateral, blood circulation promoting and dispersing pathogen accumulation.
Described Chinese medicine composition also comprises 20-40 parts of purslane speedwell Herbas, 20-40 parts of Agkistrodons, 10-40 parts of Herba Asaris.Purslane speedwell Herba is returned kidney, urinary bladder channel, have invigorate blood circulation, the effect of hemostasis, reducing swelling and alleviating pain; Agkistrodon returns the liver spleen channel, has dispelling, collateral-activating, arresting convulsion abirritative effect; Herba Asari GUIXIN, lung, kidney channel have wind-expelling pain-stopping, the effect of the cold expelling that induces sweat.
Described Chinese medicine composition comprises following bulk drugs: 30-45 parts of Herba Lycopodiis, 15-30 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris, 20-30 parts of Rhizoma Et Radix Notopterygiis, 20-40 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-10 parts of Squama Maniss.
Described Chinese medicine composition comprises following bulk drugs: 30-45 parts of Herba Lycopodiis, 10-20 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris, 25-35 parts of Rhizoma Et Radix Notopterygiis, 20-30 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss, 10-15 parts of Radixs Stephaniae Tetrandrae, 20-40 parts of Rhizoma Homalomenaes, 20-40 parts of Rhizoma Cibotii, 20-40 parts of Radix Notoginseng.
Described Chinese medicine composition comprises following bulk drugs: 30-45 parts of Herba Lycopodiis, 15-30 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris, 10-15 parts of Radixs Stephaniae Tetrandrae, 20-40 parts of Rhizoma Homalomenaes, 20-40 parts of Rhizoma Cibotii, 20-40 parts of Radix Notoginseng, 25-35 parts of Rhizoma Et Radix Notopterygiis, 20-30 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss, 20-30 parts of Radix Dipsacis, 15-25 parts of Rhizoma Curculiginises, 10-15 parts of Rhizoma Cimicifugaes, 10-20 parts of Rhizoma Corydalis Decumbentiss, 10-25 parts on Flos Carthami, 10-30 parts of Herba Sarcandraes, 20-30 parts of purslane speedwell Herbas, 20-30 parts of Agkistrodons, 10-20 parts of Herba Asaris.
Chinese medicine composition proposed by the invention is a monarch drug with the crude drug of Herba Lycopodii and liver and kidney tonifying in thousand, to have relaxing muscles and tendons to promote blood circulation, the Radix Clematidis of expelling wind and removing dampness etc. is a ministerial drug, with the Radix Phytolaccae of reducing swelling and alleviating pain and Radix Stephaniae Tetrandrae etc. is left medicine, and be messenger drug with Fructus Liquidambaris and the Squama Manis with the meridian dredging effect, this compatibility can fundamentally be cured vertebrae disease.
The affected part that above-mentioned Chinese medicine composition can be ground into powder the back or outward spread on spondylopathy patient according to the dosage and the method for Chinese medicine cream with the moxibustion of Chinese liquor wine after 1 year, and change medicine every day one time.The inventor is 120 vertebrae disease patients is treated, and wherein, the drug of topical application whole pain relieving in 3 days has 6 patients to recover in 5 days, has 108 patients to recover in 10 days, and 4 patients recovered in 15 days, and effective percentage reaches more than 98%.Healing time length is directly proportional with sick time, and its two patients do not recover, and is by due to the wound because of vertebrae disease.In addition, the inventor finds that this Chinese medicine composition has very significantly curative effect to prolapse of lumbar intervertebral disc, also waist diseases such as the pain in the lumbar region of suffering from a deficiency of the kidney, lumbar muscle strain, end ilium joint strain, back of the body psoas muscle strain, sciatica, multitude's shape flesh syndrome is also had specially good effect simultaneously.
The specific embodiment
Embodiment 1
Get 397 kilograms of Herba Lycopodiis, 238 kilograms of Radix Puerariaes, 175 kilograms of Herba speranskiae tuberculataes, 190 kilograms of Fructus Liquidambaris grind to form mix homogeneously behind the fine powder with said medicine, are Chinese medicine composition proposed by the invention.In use, this Chinese medicine composition can be made plaster according to traditional method and dosage and spread on the affected part outward, perhaps the fine powder of Chinese medicine composition be used the wine moxibustion 10-12 month, make plaster according to traditional method and dosage again and spread on the affected part outward.
Embodiment 2
Get 400 kilograms of Herba Lycopodiis, 267 kilograms of Radix Puerariaes, 160 kilograms of Herba speranskiae tuberculataes, 173 kilograms of Fructus Liquidambaris, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 3
Get 474 kilograms of Herba Lycopodiis, 263 kilograms of Radix Puerariaes, 137 kilograms of Herba speranskiae tuberculataes, 126 kilograms of Fructus Liquidambaris, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 4
Get 159 kilograms of Herba Lycopodiis, 96 kilograms of Radix Puerariaes, 76 kilograms of Herba speranskiae tuberculataes, 83 kilograms of Fructus Liquidambaris, 76 kilograms of Radixs Stephaniae Tetrandrae, 191 kilograms of Rhizoma Homalomenaes, 159 kilograms of Rhizoma Cibotii, 160 kilograms of Radix Notoginseng, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 5
Get 166 kilograms of Herba Lycopodiis, 110 kilograms of Radix Puerariaes, 61 kilograms of Herba speranskiae tuberculataes, 66 kilograms of Fructus Liquidambaris, 72 kilograms of Radixs Stephaniae Tetrandrae, 193 kilograms of Rhizoma Homalomenaes, 166 kilograms of Rhizoma Cibotii, 166 kilograms of Radix Notoginseng, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 6
Get 201 kilograms of Herba Lycopodiis, 107 kilograms of Radix Puerariaes, 61 kilograms of Herba speranskiae tuberculataes, 61 kilograms of Fructus Liquidambaris, 66 kilograms of Radixs Stephaniae Tetrandrae, 211 kilograms of Rhizoma Homalomenaes, 149 kilograms of Rhizoma Cibotii, 144 kilograms of Radix Notoginseng, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 7
Get 170 kilograms of Herba Lycopodiis, 102 kilograms of Radix Puerariaes, 75 kilograms of Herba speranskiae tuberculataes, 82 kilograms of Fructus Liquidambaris, 170 kilograms of Rhizoma Et Radix Notopterygiis, 170 kilograms of Radix Clematidis, 75 kilograms of Radix Phytolaccaes, 82 kilograms of Flos Caryophyllis, 74 kilograms of Squama Maniss, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 8
Get 174 kilograms of Herba Lycopodiis, 116 kilograms of Radix Puerariaes, 70 kilograms of Herba speranskiae tuberculataes, 75 kilograms of Fructus Liquidambaris, 176 kilograms of Rhizoma Et Radix Notopterygiis, 174 kilograms of Radix Clematidis, 70 kilograms of Radix Phytolaccaes, 75 kilograms of Flos Caryophyllis, 70 kilograms of Squama Maniss, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 9
Get 217 kilograms of Herba Lycopodiis, 120 kilograms of Radix Puerariaes, 62 kilograms of Herba speranskiae tuberculataes, 67 kilograms of Fructus Liquidambaris, 168 kilograms of Rhizoma Et Radix Notopterygiis, 168 kilograms of Radix Clematidis, 62 kilograms of Radix Phytolaccaes, 67 kilograms of Flos Caryophyllis, 62 kilograms of Squama Maniss, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 10
Get 103 kilograms of Herba Lycopodiis, 62 kilograms of Radix Puerariaes, 45 kilograms of Herba speranskiae tuberculataes, 49 kilograms of Fructus Liquidambaris, 103 kilograms of Rhizoma Et Radix Notopterygiis, 103 kilograms of Radix Clematidis, 45 kilograms of Radix Phytolaccaes, 49 kilograms of Flos Caryophyllis, 45 kilograms of Squama Maniss, 103 kilograms of Radix Dipsacis, 62 kilograms of Rhizoma Curculiginises, 45 kilograms of Rhizoma Cimicifugaes, 62 kilograms of Rhizoma Corydalis Decumbentiss, 62 kilograms on Flos Carthami, 62 kilograms of Herba Sarcandraes, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 11
Get 96 kilograms of Herba Lycopodiis, 71 kilograms of Radix Puerariaes, 43 kilograms of Herba speranskiae tuberculataes, 46 kilograms of Fructus Liquidambaris, 96 kilograms of Rhizoma Et Radix Notopterygiis, 96 kilograms of Radix Clematidis, 43 kilograms of Radix Phytolaccaes, 46 kilograms of Flos Caryophyllis, 43 kilograms of Squama Maniss, 96 kilograms of Radix Dipsacis, 68 kilograms of Rhizoma Curculiginises, 43 kilograms of Rhizoma Cimicifugaes, 71 kilograms of Rhizoma Corydalis Decumbentiss, 71 kilograms on Flos Carthami, 71 kilograms of Herba Sarcandraes, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 12
Get 128 kilograms of Herba Lycopodiis, 77 kilograms of Radix Puerariaes, 40 kilograms of Herba speranskiae tuberculataes, 43 kilograms of Fructus Liquidambaris, 97 kilograms of Rhizoma Et Radix Notopterygiis, 97 kilograms of Radix Clematidis, 40 kilograms of Radix Phytolaccaes, 43 kilograms of Flos Caryophyllis, 40 kilograms of Squama Maniss, 97 kilograms of Radix Dipsacis, 77 kilograms of Rhizoma Curculiginises, 40 kilograms of Rhizoma Cimicifugaes, 66 kilograms of Rhizoma Corydalis Decumbentiss, 75 kilograms on Flos Carthami, 76 kilograms of Herba Sarcandraes, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 13
Get 85 kilograms of Herba Lycopodiis, 55 kilograms of Radix Puerariaes, 34 kilograms of Herba speranskiae tuberculataes, 37 kilograms of Fructus Liquidambaris, 85 kilograms of Rhizoma Et Radix Notopterygiis, 85 kilograms of Radix Clematidis, 34 kilograms of Radix Phytolaccaes, 36 kilograms of Flos Caryophyllis, 34 kilograms of Squama Maniss, 85 kilograms of Radix Dipsacis, 46 kilograms of Rhizoma Curculiginises, 34 kilograms of Rhizoma Cimicifugaes, 45 kilograms of Rhizoma Corydalis Decumbentiss, 45 kilograms on Flos Carthami, 45 kilograms of Herba Sarcandraes, 85 kilograms of purslane speedwell Herbas, 85 kilograms of Agkistrodons, 45 kilograms of Herba Asaris, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 14
Get 83 kilograms of Herba Lycopodiis, 52 kilograms of Radix Puerariaes, 31 kilograms of Herba speranskiae tuberculataes, 34 kilograms of Fructus Liquidambaris, 83 kilograms of Rhizoma Et Radix Notopterygiis, 83 kilograms of Radix Clematidis, 32 kilograms of Radix Phytolaccaes, 33 kilograms of Flos Caryophyllis, 31 kilograms of Squama Maniss, 78 kilograms of Radix Dipsacis, 52 kilograms of Rhizoma Curculiginises, 31 kilograms of Rhizoma Cimicifugaes, 52 kilograms of Rhizoma Corydalis Decumbentiss, 52 kilograms on Flos Carthami, 52 kilograms of Herba Sarcandraes, 78 kilograms of purslane speedwell Herbas, 78 kilograms of Agkistrodons, 65 kilograms of Herba Asaris, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 15
Get 101 kilograms of Herba Lycopodiis, 59 kilograms of Radix Puerariaes, 27 kilograms of Herba speranskiae tuberculataes, 29 kilograms of Fructus Liquidambaris, 79 kilograms of Rhizoma Et Radix Notopterygiis, 79 kilograms of Radix Clematidis, 28 kilograms of Radix Phytolaccaes, 29 kilograms of Flos Caryophyllis, 27 kilograms of Squama Maniss, 79 kilograms of Radix Dipsacis, 52 kilograms of Rhizoma Curculiginises, 27 kilograms of Rhizoma Cimicifugaes, 52 kilograms of Rhizoma Corydalis Decumbentiss, 52 kilograms on Flos Carthami, 52 kilograms of Herba Sarcandraes, 80 kilograms of purslane speedwell Herbas, 74 kilograms of Agkistrodons, 74 kilograms of Herba Asaris, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 16
Get 138 kilograms of Herba Lycopodiis, 54 kilograms of Radix Puerariaes, 43 kilograms of Herba speranskiae tuberculataes, 43 kilograms of Fructus Liquidambaris, 102 kilograms of Rhizoma Et Radix Notopterygiis, 90 kilograms of Radix Clematidis, 43 kilograms of Radix Phytolaccaes, 47 kilograms of Flos Caryophyllis, 43 kilograms of Squama Maniss, 43 kilograms of Radixs Stephaniae Tetrandrae, 102 kilograms of Rhizoma Homalomenaes, 126 kilograms of Rhizoma Cibotii, 90 kilograms of Radix Notoginseng, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Embodiment 17
Get 90 kilograms of Herba Lycopodiis, 46 kilograms of Radix Puerariaes, 27 kilograms of Herba speranskiae tuberculataes, 25 kilograms of Fructus Liquidambaris, 27 kilograms of Radixs Stephaniae Tetrandrae, 73 kilograms of Rhizoma Homalomenaes, 73 kilograms of Rhizoma Cibotii, 71 kilograms of Radix Notoginseng, 63 kilograms of Rhizoma Et Radix Notopterygiis, 53 kilograms of Radix Clematidis, 25 kilograms of Radix Phytolaccaes, 27 kilograms of Flos Caryophyllis, 27 kilograms of Squama Maniss, 53 kilograms of Radix Dipsacis, 42 kilograms of Rhizoma Curculiginises, 27 kilograms of Rhizoma Cimicifugaes, 32 kilograms of Rhizoma Corydalis Decumbentiss, 42 kilograms on Flos Carthami, 42 kilograms of Herba Sarcandraes, 52 kilograms of purslane speedwell Herbas, 52 kilograms of Agkistrodons, 31 kilograms of Herba Asaris, the method for making Chinese medicine composition is identical with embodiment 1 with using method.
Claims (8)
1, a kind of Chinese medicine composition for the treatment of vertebrae disease is characterized in that: this Chinese medicine composition comprises following row bulk drugs: 20-50 parts of Herba Lycopodiis, 10-30 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris.
2, Chinese medicine composition according to claim 1 is characterized in that: also comprise 10-15 parts of Radixs Stephaniae Tetrandrae, 20-50 parts of Rhizoma Homalomenaes, 20-40 parts of Rhizoma Cibotii, 20-40 parts of Radix Notoginseng.
3, Chinese medicine composition according to claim 1 and 2 is characterized in that: also comprise 20-40 parts of Rhizoma Et Radix Notopterygiis, 20-40 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss.
4, Chinese medicine composition according to claim 3 is characterized in that: also comprise 20-40 parts of Radix Dipsacis, 10-30 parts of Rhizoma Curculiginises, 10-15 parts of Rhizoma Cimicifugaes, 10-30 parts of Rhizoma Corydalis Decumbentiss, 10-30 parts on Flos Carthami, 10-30 parts of Herba Sarcandraes.
5, Chinese medicine composition according to claim 4 is characterized in that: also comprise 20-40 parts of purslane speedwell Herbas, 20-40 parts of Agkistrodons, 10-40 parts of Herba Asaris.
6, Chinese medicine composition according to claim 3, it is characterized in that: this Chinese medicine composition comprises following bulk drugs: 30-45 parts of Herba Lycopodiis, 15-30 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris, 20-30 parts of Rhizoma Et Radix Notopterygiis, 20-40 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss.
7, Chinese medicine composition according to claim 3 is characterized in that: this Chinese medicine composition comprises following bulk drugs: 30-45 parts of Herba Lycopodiis, 10-20 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris, 25-35 parts of Rhizoma Et Radix Notopterygiis, 20-30 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss, 10-15 parts of Radixs Stephaniae Tetrandrae, 20-40 parts of Rhizoma Homalomenaes, 20-40 parts of Rhizoma Cibotii, 20-40 parts of Radix Notoginseng.
8, Chinese medicine composition according to claim 5 is characterized in that: this Chinese medicine composition comprises following bulk drugs: 30-45 parts of Herba Lycopodiis, 15-30 parts of Radix Puerariaes, each 10-15 part of Herba speranskiae tuberculatae and Fructus Liquidambaris, 10-15 parts of Radixs Stephaniae Tetrandrae, 20-40 parts of Rhizoma Homalomenaes, 20-40 parts of Rhizoma Cibotii, 20-40 parts of Radix Notoginseng, 25-35 parts of Rhizoma Et Radix Notopterygiis, 20-30 parts of Radix Clematidis, 10-15 parts of Radix Phytolaccaes, 10-15 parts of Flos Caryophyllis, 10-15 parts of Squama Maniss, 20-30 parts of Radix Dipsacis, 15-25 parts of Rhizoma Curculiginises, 10-15 parts of Rhizoma Cimicifugaes, 10-20 parts of Rhizoma Corydalis Decumbentiss, 10-25 parts on Flos Carthami, 10-30 parts of Herba Sarcandraes, 20-30 parts of purslane speedwell Herbas, 20-30 parts of Agkistrodons, 10-20 parts of Herba Asaris.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102286756A CN101417003A (en) | 2008-11-11 | 2008-11-11 | Traditional Chinese medicine composition for treating vertebras disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008102286756A CN101417003A (en) | 2008-11-11 | 2008-11-11 | Traditional Chinese medicine composition for treating vertebras disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101417003A true CN101417003A (en) | 2009-04-29 |
Family
ID=40628129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008102286756A Pending CN101417003A (en) | 2008-11-11 | 2008-11-11 | Traditional Chinese medicine composition for treating vertebras disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101417003A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102311111A (en) * | 2010-06-29 | 2012-01-11 | 张洪溧 | Method and application for burying and calcining plant carbon |
| CN104147403A (en) * | 2014-07-16 | 2014-11-19 | 太仓思瑞生物科技有限公司 | Drug for preventing and treating cervical spondylosis |
| CN104324086A (en) * | 2014-10-16 | 2015-02-04 | 韦爱小 | External-use traditional Chinese medicine for treating cervical spondylosis |
| CN104436050A (en) * | 2014-12-05 | 2015-03-25 | 北京大学深圳医院 | Chinese medicinal composition used as neck pillow packed layer and neck pillow |
| CN104784264A (en) * | 2014-09-18 | 2015-07-22 | 韦金富 | Traditional Chinese medicine for treating cervical spondylosis |
-
2008
- 2008-11-11 CN CNA2008102286756A patent/CN101417003A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102311111A (en) * | 2010-06-29 | 2012-01-11 | 张洪溧 | Method and application for burying and calcining plant carbon |
| CN104147403A (en) * | 2014-07-16 | 2014-11-19 | 太仓思瑞生物科技有限公司 | Drug for preventing and treating cervical spondylosis |
| CN104784264A (en) * | 2014-09-18 | 2015-07-22 | 韦金富 | Traditional Chinese medicine for treating cervical spondylosis |
| CN104324086A (en) * | 2014-10-16 | 2015-02-04 | 韦爱小 | External-use traditional Chinese medicine for treating cervical spondylosis |
| CN104436050A (en) * | 2014-12-05 | 2015-03-25 | 北京大学深圳医院 | Chinese medicinal composition used as neck pillow packed layer and neck pillow |
| CN104436050B (en) * | 2014-12-05 | 2018-03-06 | 北京大学深圳医院 | A kind of Chinese medicine composition and neckpillow as neckpillow packed layer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102294008A (en) | Chinese medicine for treating cervical spondylosis, lumbar disc herniation slipped disc, sciatica and femoral head lesion | |
| CN103191377A (en) | Plaster for treating rheumatoid bone diseases | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN102309723B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN101264146B (en) | Externally-applied Chinese herbal medicine for treating bones and muscles disease and preparation thereof | |
| CN102526409B (en) | Chinese medicinal composition for treating tennis elbow | |
| CN101417003A (en) | Traditional Chinese medicine composition for treating vertebras disease | |
| CN101664455B (en) | Chinese medicinal composition for treating lumbago and preparation method | |
| CN102698085B (en) | Chinese medicinal plaster for treating arthritis | |
| CN102716210B (en) | Traditional Chinese medicine for treating rheumatism and production method thereof | |
| CN101703619A (en) | Chinese medicament for treating hyperosteogeny and osteoarthritis | |
| CN101954040A (en) | Externally-applied medicament for treating hyperosteogeny and preparation method thereof | |
| CN106236964A (en) | A kind of Chinese medicine treating joint disease | |
| CN102764355B (en) | Traditional Chinese medicine composite for curing femoral head necrosis | |
| CN102370836B (en) | External application traditional Chinese medicine for treating traumatic synovitis | |
| CN101129630B (en) | Medicament for treating rheumatism, arthritis pauperum | |
| CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
| CN104706749A (en) | Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion | |
| CN104173584A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN103110742A (en) | Chinese medicine preparation for treating sciatica | |
| CN102861197A (en) | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains | |
| CN102579613A (en) | Oral Chinese medicinal composition for treating rheumatism pain | |
| CN102416049A (en) | Small square type rheumatoid swelling diminishing and pain eliminating plaster and preparation method thereof | |
| CN102416053A (en) | Medicinal moxaroll for treating sciatica and preparation method thereof | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090429 |